Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

Xadago (safinamide) tablets have been approved by the U.S. Food and Drug Administration as an add-on drug to treat Parkinson's patients who take levodopa or carbidopa but experience "off" episodes.

FDA Approves New Parkinson’s Add-On Drug Xadago

0
To help prevent 'off' episodes among users of levodopa/carbidopa
Noctiva (desmopressin acetate) nasal spray has been approved by the U.S. Food and Drug Administration to treat frequent urination at night due to nocturnal polyuria.

FDA Approves Noctiva Nasal Spray for Nocturnal Polyuria

0
Drug designed to increase absorption of water through the kidneys, decreasing urine production
A new treatment for dust mite allergies has been approved by the U.S. Food and Drug Administration.

FDA Approves Odactra for House Dust Mite Allergies

0
Year-round, once-a-day tablet that's taken sublingually
Xermelo (telotristat ethyl) tablets have been approved by the U.S. Food and Drug Administration to treat adults with carcinoid syndrome diarrhea.

FDA Approves Xermelo for Carcinoid Syndrome Diarrhea

0
Oral tablets to be used in combination with somatostatin analog therapy
The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults.

FDA Approves Siliq for Plaque Psoriasis

0
Injected medication approved for use by patients who've failed other treatments
Emflaza (deflazacort) has been approved by the U.S. Food and Drug Administration to treat Duchenne muscular dystrophy in patients 5 years and older

FDA Approves Emflaza for Duchenne Muscular Dystrophy

0
Approved to treat Duchenne muscular dystrophy in patients 5 years and older
A set of screening tests designed to detect four rare metabolic disorders in newborns has been approved by the U.S. Food and Drug Administration.

FDA Approves Newborn Screening Tests for Metabolic Disorders

0
Screens used to detect Mucopolysaccharidosis Type 1, Pompe, Gaucher, and Fabry
Extending the market exclusivity for existing drugs that are granted subsequent U.S. Food and Drug Administration approval for a new rare disease indication would provide manufacturers with substantial compensation

Extending Rx Exclusivity Could Boost Study for Rare Diseases

0
Substantial compensation to many drug manufacturers, especially for top-selling products
Trulance has been approved by the U.S. Food and Drug Administration to treat persistent idiopathic constipation in adults.

FDA Approves Trulance for Chronic Idiopathic Constipation

0
Drug designed to stimulate secretion of intestinal fluid
A new U.S. government guideline classifies fish into three categories of safety to help pregnant women

FDA, EPA Issue Guidance on Fish Consumption

0
Recommendations aimed at pregnant women, breastfeeding mothers, parents of young children